Literature DB >> 31933465

Risk and Protective Factors for Cholera Deaths during an Urban Outbreak-Lusaka, Zambia, 2017-2018.

Lwito Salifya Mutale1, Alison V Winstead2, Patrick Sakubita1, Fred Kapaya1, Sulani Nyimbili3, Nelia L Mulambya1, Francis H Nanzaluka1, Angela Gama1, Vivian Mwale1, Sunkyung Kim2, William Ngosa4, Ellen Yard5,1, Nyambe Sinyange4,1, Eric Mintz2, Joan Brunkard2, Victor Mukonka4.   

Abstract

The Republic of Zambia declared a cholera outbreak in Lusaka, the capital, on October 6, 2017. By mid-December, 20 of 661 reported cases had died (case fatality rate 3%), prompting the CDC and the Zambian Ministry of Health through the Zambia National Public Health Institute to investigate risk factors for cholera mortality. We conducted a study of cases (cholera deaths from October 2017 to January 2018) matched by age-group and onset date to controls (persons admitted to a cholera treatment center [CTC] and discharged alive). A questionnaire was administered to each survivor (or relative) and to a family member of each decedent. We used univariable exact conditional logistic regression to calculate matched odds ratios (mORs) and 95% CIs. In the analysis, 38 decedents and 76 survivors were included. Median ages for decedents and survivors were 38 (range: 0.5-95) and 25 (range: 1-82) years, respectively. Patients aged > 55 years and those who did not complete primary school had higher odds of being decedents (matched odds ratio [mOR] 6.3, 95% CI: 1.2-63.0, P = 0.03; mOR 8.6, 95% CI: 1.8-81.7, P < 0.01, respectively). Patients who received immediate oral rehydration solution (ORS) at the CTC had lower odds of dying than those who did not receive immediate ORS (mOR 0.1, 95% CI: 0.0-0.6, P = 0.02). Cholera prevention and outbreak response should include efforts focused on ensuring access to timely, appropriate care for older adults and less educated populations at home and in health facilities.

Entities:  

Mesh:

Year:  2020        PMID: 31933465      PMCID: PMC7056416          DOI: 10.4269/ajtmh.19-0678

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Spatial analysis of risk factor of cholera outbreak for 2003-2004 in a peri-urban area of Lusaka, Zambia.

Authors:  Satoshi Sasaki; Hiroshi Suzuki; Kumiko Igarashi; Bushimbwa Tambatamba; Philip Mulenga
Journal:  Am J Trop Med Hyg       Date:  2008-09       Impact factor: 2.345

2.  Factors Associated with Fatal Outcomes Following Cholera-Like Syndrome in Far North Region of Cameroon: A Community-Based Survey.

Authors:  Fabrice N Djouma; Jerome Ateudjieu; Malathi Ram; Amanda K Debes; David A Sack
Journal:  Am J Trop Med Hyg       Date:  2016-10-17       Impact factor: 2.345

3.  Reducing deaths from diarrhoea through oral rehydration therapy.

Authors:  C G Victora; J Bryce; O Fontaine; R Monasch
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

4.  Oral fluid therapy of cholera among Bangladesh refugees.

Authors:  D Mahalanabis; A B Choudhuri; N G Bagchi; A K Bhattacharya; T W Simpson
Journal:  Johns Hopkins Med J       Date:  1973-04

5.  Single-Dose Cholera Vaccine in Response to an Outbreak in Zambia.

Authors:  Eva Ferreras; Elizabeth Chizema-Kawesha; Alexandre Blake; Orbrie Chewe; John Mwaba; Gideon Zulu; Marc Poncin; Ankur Rakesh; Anne-Laure Page; Savina Stoitsova; Caroline Voute; Florent Uzzeni; Hugues Robert; Micaela Serafini; Belem Matapo; Jose-María Eiros; Marie-Laure Quilici; Lorenzo Pezzoli; Andrew S Azman; Sandra Cohuet; Iza Ciglenecki; Kennedy Malama; Francisco J Luquero
Journal:  N Engl J Med       Date:  2018-02-08       Impact factor: 91.245

6.  Recurrent epidemic cholera with high mortality in Cameroon: persistent challenges 40 years into the seventh pandemic.

Authors:  E J Cartwright; M K Patel; F X Mbopi-Keou; T Ayers; B Haenke; B H Wagenaar; E Mintz; R Quick
Journal:  Epidemiol Infect       Date:  2013-01-07       Impact factor: 4.434

7.  Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia.

Authors:  Marc Poncin; Gideon Zulu; Caroline Voute; Eva Ferreras; Clara Mbwili Muleya; Kennedy Malama; Lorenzo Pezzoli; Jacob Mufunda; Hugues Robert; Florent Uzzeni; Francisco J Luquero; Elizabeth Chizema; Iza Ciglenecki
Journal:  Bull World Health Organ       Date:  2017-10-19       Impact factor: 9.408

8.  Seroepidemiologic survey of epidemic cholera in Haiti to assess spectrum of illness and risk factors for severe disease.

Authors:  Brendan R Jackson; Deborah F Talkington; James M Pruckler; M D Bernadette Fouché; Elsie Lafosse; Benjamin Nygren; Gerardo A Gómez; Georges A Dahourou; W Roodly Archer; Amanda B Payne; W Craig Hooper; Jordan W Tappero; Gordana Derado; Roc Magloire; Peter Gerner-Smidt; Nicole Freeman; Jacques Boncy; Eric D Mintz
Journal:  Am J Trop Med Hyg       Date:  2013-10       Impact factor: 2.345

Review 9.  Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis.

Authors:  Qifang Bi; Eva Ferreras; Lorenzo Pezzoli; Dominique Legros; Louise C Ivers; Kashmira Date; Firdausi Qadri; Laura Digilio; David A Sack; Mohammad Ali; Justin Lessler; Francisco J Luquero; Andrew S Azman
Journal:  Lancet Infect Dis       Date:  2017-07-17       Impact factor: 25.071

10.  Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study.

Authors:  Molly F Franke; Ralph Ternier; J Gregory Jerome; Wilfredo R Matias; Jason B Harris; Louise C Ivers
Journal:  Lancet Glob Health       Date:  2018-09       Impact factor: 26.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.